Treatments · Entity Annotation Prototype (beta)

1articles mentioning treatments

1treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: autologous thymus-derived Treg cell therapy ×

autologous thymus-derived Treg cell therapy

This treatment is selected. Its supporting articles are shown below.

autologous thymus-derived Treg cell therapy1

Articles mentioning autologous thymus-derived Treg cell therapy

1 articles · page 1 of 1

Protocol for a phase I single-centre dose escalation trial of autologous thymus derived regulatory T cells in paediatric heart transplant recipients to prevent cardiac allograft vasculopathy (ATT-Heart)

bmjopen · abstract · 2026-05-21 · 1 matching annotations

75.2%

immunosuppression autologous thymus-derived Treg cell therapy Great Ormond Street Hospital TR006 Cardiac allograft vasculopathy (CAV)UK Medicines and Healthcare products Regulatory Agency

…lant standard of care protocol with no wean of standard of care immunosuppression. Primary endpoint includes occurrence of Dose-limiting Toxiciti…

Browse treatments

autologous thymus-derived Treg cell therapy

Articles mentioning autologous thymus-derived Treg cell therapy

Protocol for a phase I single-centre dose escalation trial of autologous thymus derived regulatory T cells in paediatric heart transplant recipients to prevent cardiac allograft vasculopathy (ATT-Heart)